SARS-CoV-2 infection and autoimmunity

Z Rheumatol. 2023 Dec 18. doi: 10.1007/s00393-023-01455-x. Online ahead of print.ABSTRACTEven in the early phase of the corona pandemic in 2020, severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) was referred to as an "autoimmune virus". Since then, there have been numerous reports on the increased incidence of autoantibodies and autoimmune phenomena after SARS-CoV‑2 infections. On the one hand, autoantibodies can influence the course of the disease and on the other hand, they can lead to the first manifestation of new autoimmune diseases. In addition, a role of autoantibodies in the pathogenesis of post-coronavirus disease (post-COVID) is discussed. In the present review article, important aspects and studies are listed and the possible therapeutic consequences resulting from the findings are presented.PMID:38108865 | DOI:10.1007/s00393-023-01455-x
Source: Zeitschrift fur Rheumatologie - Category: Rheumatology Authors: Source Type: research